National Institutes of Health, 10 Center Drive, Building 10, Room 6N260, Bethesda, MD 20892-1603, USA.
J Am Soc Nephrol. 2010 Feb;21(2):303-15. doi: 10.1681/ASN.2009070728. Epub 2010 Jan 14.
Protein phosphorylation is an important component of vasopressin signaling in the renal collecting duct, but the database of known phosphoproteins is incomplete. We used tandem mass spectrometry to identify vasopressin-regulated phosphorylation events in isolated rat inner medullary collecting duct (IMCD) suspensions. Using multiple search algorithms to identify the phosphopeptides from spectral data, we expanded the size of the existing collecting duct phosphoproteome database from 367 to 1187 entries. Label-free quantification in vasopressin- and vehicle-treated samples detected a significant change in the phosphorylation of 29 of 530 quantified phosphopeptides. The targets include important structural, regulatory, and transporter proteins. The vasopressin-regulated sites included two known sites (Ser-486 and Ser-499) present in the urea channel UT-A1 and one previously unknown site (Ser-84) on vasopressin-sensitive urea channels UT-A1 and UT-A3. In vitro assays using synthetic peptides showed that purified protein kinase A (PKA) could phosphorylate all three sites, and immunoblotting confirmed the PKA dependence of Ser-84 and Ser-486 phosphorylation. These results expand the known list of collecting duct phosphoproteins and highlight the utility of targeted phosphoproteomic approaches.
蛋白质磷酸化是抗利尿激素信号在肾集合管中的一个重要组成部分,但已知磷酸化蛋白数据库并不完整。我们使用串联质谱法鉴定了分离的大鼠髓质内集合管(IMCD)悬浮液中受抗利尿激素调节的磷酸化事件。通过使用多个搜索算法从光谱数据中识别磷酸肽,我们将现有的集合管磷酸化蛋白质组数据库从 367 个条目扩展到 1187 个条目。在抗利尿激素和载体处理的样本中进行无标记定量检测,发现 530 个定量磷酸肽中有 29 个磷酸化水平发生了显著变化。这些靶点包括重要的结构、调节和转运蛋白。受抗利尿激素调节的磷酸化位点包括存在于尿素通道 UT-A1 中的两个已知位点(Ser-486 和 Ser-499)和尿素敏感通道 UT-A1 和 UT-A3 上一个以前未知的位点(Ser-84)。使用合成肽的体外实验表明,纯化的蛋白激酶 A(PKA)可以磷酸化所有三个位点,免疫印迹证实了 Ser-84 和 Ser-486 磷酸化依赖于 PKA。这些结果扩展了已知的集合管磷酸化蛋白列表,并强调了靶向磷酸化蛋白质组学方法的实用性。